A Study of the Effectiveness and Safety of Experimental Pamrevlumab for Locally Advanced, Unresectable Pancreatic Cancer
a study on Pancreatic Cancer
Pancreatic Cancer Non-resectable locally advanced pancreatic cancer unresectable pancreatic cancer Pancreatic Neoplasms Gemcitabine Paclitaxel Albumin-Bound Paclitaxel Pamrevlumab + Gemcitabine + Nab-paclitaxel
Lead Scientists at UC Cancer
- Tony Reid, MD (ucsd)
Professor Tony Reid’s main career goals are to develop novel therapeutic approaches to diagnose, prevent, and treat tumors with gene therapy vectors. He has focused on elucidating the underlying molecular mechanism that causes cancer, focusing primarily in gastrointestinal tumors including colorectal, pancreatic, esophageal and hepatobillary cancers.
- John Glaspy, MD (ucla)
Professor, Medicine. Authored (or co-authored) 123 research publications.
- Edward Kim, MD (ucdavis)
Associate Professor, Hematology and Oncology. Authored (or co-authored) 30 research publications.